In the development of neurodegenerative diseases, the excessive accumulation of amyloid beta (Aβ) causes neuronal oxidative stress, leading to cognitive impairment. Cirsium japonicum var. maackii (CJM) is a widely used medicinal material, and pectoli...
In the development of neurodegenerative diseases, the excessive accumulation of amyloid beta (Aβ) causes neuronal oxidative stress, leading to cognitive impairment. Cirsium japonicum var. maackii (CJM) is a widely used medicinal material, and pectolinarin is an active compound of CJM. This study investigated the protective effects of ethyl acetate (EtOAc) fraction of CJM (ECJM) and pectolinarin on cognitive impairment by regulation of neuronal oxidative stress. In the in vivo study, ECJM showed higher spatial memory and object recognition compared with Aβ25-35-induced control group. Besides, ECJM-administered mice showed higher learning and memory abilities than Aβ25-35-induced control mice. ECJM attenuated the oxidative stress by reduced the reactive oxygen species (ROS) production, nitrite oxide (NO) production, and lipid peroxidation in the brain. In addition, administration of ECJM attenuated neuronal oxidative stress by regulation of oxidative stress-related protein heme oxygenase-1 (HO-1) in the brain. The ECJM-administrated mice showed down-regulations of inflammation-related protein nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin 1 beta (IL-1β) , apoptosis-related protein Bcl-2 associated X protein (Bax)/B-cell lymphoma 2 (Bcl-2), and amyloidogenic pathway related protein beta-secretase 1 (BACE), presenilin1 (PS1), and presenilin2 (PS2) in Aβ25-35–induced mice brain. In addition, pectolinarin concentration-dependently increased ·OH and NO radical scavenging ability. The treatment of pectolinarin showed significantly increased cell viability, decreased the ROS production and lactate dehydrogenase (LDH) release level compared with H2O2-induced SH-SY5Y neuronal cells. Furthermore, to evaluate the neuroprotective mechanisms of pectolinarin, we measured the protein expression. Treatment of pectolinarin showed up-regulation of oxidative stress-related proteins such as nuclear factor erythroid 2-related factor 2 (Nrf2) and HO-1, while down-regulation of kelch-like ECH-associated protein 1 (Keap1) in H2O2-induced SH-SY5Y cells. The cells treated with pectolinarin down-regulated inflammation-related proteins such as iNOS, COX-2, IL-1β and apoptosis-related protein, Bax/Bcl-2 ratio in H2O2-induced SH-SY5Y cells. The present results demonstrated that ECJM had a protective effect on cognitive impairment in Aβ25-35–induced mice via attenuation of neuronal oxidative stress and pectolinarin had neuroprotective effects against H2O2-induced oxidative stress in SH-SY5Y cells. Therefore, we suggeste that CJM and pectolinarin may used as therapeutic agents in Alzheimer’s disease treatment.